tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
Company AnnouncementsStemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
3d ago
4599
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
PremiumCompany Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
10d ago
4599
StemRIM Completes New Share Issuance for Stock Compensation
PremiumCompany Announcements
StemRIM Completes New Share Issuance for Stock Compensation
10d ago
4599
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
PremiumCompany Announcements
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
10d ago
4599
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
PremiumCompany Announcements
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
24d ago
4599
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
PremiumCompany AnnouncementsStemRIM Inc. Issues New Shares for Restricted Stock Remuneration
1M ago
4599
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
Premium
Company Announcements
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
2M ago
4599
StemRIM Secures US Patent for Psoriasis Treatment
Premium
Company Announcements
StemRIM Secures US Patent for Psoriasis Treatment
3M ago
4599
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
PremiumCompany Announcements
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
3M ago
4599
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
PremiumCompany Announcements
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
3M ago
4599
StemRIM Inc. Reports Fiscal Year 2025 Financial Results and Strategic Progress
PremiumCompany Announcements
StemRIM Inc. Reports Fiscal Year 2025 Financial Results and Strategic Progress
3M ago
4599
StemRIM Inc. Announces Stock Options for Directors
PremiumCompany Announcements
StemRIM Inc. Announces Stock Options for Directors
3M ago
4599
StemRIM Inc. Issues Stock Options to Employees
PremiumCompany AnnouncementsStemRIM Inc. Issues Stock Options to Employees
3M ago
4599
StemRIM Inc. Issues Stock Options to Boost R&D and Shareholder Value
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Boost R&D and Shareholder Value
3M ago
4599
StemRIM Inc. Issues Stock Options to Enhance Employee Motivation and Company Value
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Enhance Employee Motivation and Company Value
3M ago
4599
StemRIM Inc. Issues Stock Options to Directors
PremiumCompany Announcements
StemRIM Inc. Issues Stock Options to Directors
3M ago
4599
StemRIM Inc. Reports Financial Results and Future Outlook
PremiumCompany Announcements
StemRIM Inc. Reports Financial Results and Future Outlook
3M ago
4599
StemRIM Completes Enrollment for Redasemtide Phase 2 Trial
PremiumCompany Announcements
StemRIM Completes Enrollment for Redasemtide Phase 2 Trial
5M ago
4599
StemRIM Inc. Reports Financial Results and R&D Focus Amid Losses
PremiumCompany Announcements
StemRIM Inc. Reports Financial Results and R&D Focus Amid Losses
6M ago
4599
StemRIM Secures European Patent for Cartilage Disorder Treatment
PremiumCompany AnnouncementsStemRIM Secures European Patent for Cartilage Disorder Treatment
7M ago
4599
StemRIM Inc. Announces Shareholder Meeting and Capital Reduction
Premium
Company Announcements
StemRIM Inc. Announces Shareholder Meeting and Capital Reduction
9M ago
4599
StemRIM Secures Chinese Patent for Redasemtide, Boosting Global Expansion
Premium
Company Announcements
StemRIM Secures Chinese Patent for Redasemtide, Boosting Global Expansion
9M ago
4599

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >